10% Owner Kevin Tang Buys $891K of Fulcrum Stock After Pipeline Collapse
FULC sits 26% above its 52-week low of $2.83 on light trading volume (0.4× avg).
Summary
10% owner Kevin Tang bought $891K of Fulcrum stock in open-market purchases, a notable vote of confidence following the company's recent pipeline failure and restructuring.
Key Events · Ownership and Investor Activity · FULC
-
10% Owner Buys $891K in Stock
Kevin Tang, through affiliated entities, purchased 249,946 shares for $891,067 at prices between $3.50 and $3.60 from July 13-15, increasing his indirect holdings to 6,913,329 shares.
-
Post-Crisis Conviction Buy
The purchase follows Fulcrum's June 1 discontinuation of its lead sickle cell drug and an 85% workforce reduction, suggesting Tang sees value in the remaining pipeline and cash runway.
-
No Prior Disclosure
This Form 4 is the first public disclosure of these transactions; no earlier filings or news reported the purchases.
Analysis · FULC · Life Sciences
Kevin Tang, a 10% owner, spent $891,067 buying 249,946 shares on the open market over three days at prices near $3.56. This comes just six weeks after Fulcrum discontinued its lead sickle cell program and slashed 85% of its workforce. The purchase signals conviction from a large, informed investor that the remaining pipeline and cash runway justify the current valuation, even as the company navigates a strategic review.
At the time of this filing, FULC was trading at $3.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $237.2M. The 52-week trading range was $2.83 to $15.74. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.